Clinical Trial Details


Back to Clinical Trials Database

A randomized double blind phase III trial of Pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or following prior therapy.

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 01-Oct-2008
Date Step1 close: 08-Mar-2010
Data management at EORTC Yes
Design Phase 3
Randomized blind
Targeted Sample size All Groups: 255
Treatment Pazopanib
Study Staff
Type of cancer
Participating groups EORTC Soft Tissue and Bone Sarcoma Group
Protocol summary
NCT number NCT00794521
EudraCT 2008-001307-33